LIPOSOMAL FORM WITH LIPOIC ACID AND CARNOSINE: PRODUCTION, ANTIPLATELET AND ANTIOXIDANT EFFECT
Author:
Shchelkonogov V.123, Baranova O.23, Chekanov A.23, Kazarinov K.4, Shastina N.1, Stvolinsky S.5, Fedorova T.5, Solovieva E.2, Fedin A.2, Sorokoumova G.1
Affiliation:
1. MIREA - Russian Technological University 2. Pirogov Russian National Research Medical University 3. Kotelnikov Institute of Radioengineering and Electronics of RAS 4. Kotelnikov Institute of Radioengineering and Electronics, RAS 5. Research Center of Neurology, Laboratory of Clinical and Experimental Neurochemistry
Abstract
Optimal conditions were selected for obtaining the liposomal form with lipoic acid (LA) and carnosine. Using methods of active and passive loading, it was possible to achieve high efficiency inclusion of carnosine (60±5%) and lipoic acid (75±5%) in nanoparticles (NPs). It has been shown that the addition of sucrose or cholesterol (Chol) to nanodispersions (NDs) led to a slight decrease in the efficiency incorporation of carnosine in nanoparticles (45±5%). The production of PC-liposomes (PC-Ls) with LA and carnosine by passive loading led to a significant decrease in the efficiency inclusion of carnosine in liposomes (16%). At the same time, the efficiency of inclusion of LA in PC liposomes using methods of both passive and active loading practically did not change (58-69%). It has been found that the obtained nanodispersions are homogeneous system of nanoparticles with size of 175-250 nm. By transmission electron microscopy, it has been shown that LA+Carn. Liposomes represent a homogeneous system consisting mainly of spherical nanoparticles with a size of 120-200 nm. It is important to note that the obtained liposomes with LA and carnosine are stable during long-term storage (15 months) at + 4 ° and at room temperature. It was established that liposomes LA with Carn exhibit an antioxidant effect, leading to a 15-fold decrease in the concentration of lipid peroxidation products. The effect of the obtained liposomal forms on platelet aggregation caused by arachidonic acid has been revealed. It has been found, that liposomes with LA and carnosine reduce the degree of aggregation of platelets by 60-70%, relative to controls.
Publisher
RIOR Publishing Center
Reference15 articles.
1. Бурчинский С.Г. Ишемия головного мозга: возможности комплексной фармакологической коррекции. Статьи института геронтологии АМН Украины, 2006, т. 14, c. 15-18., Burchinsky S.G. Brain ischemia: the possibilities of complex pharmacological correction. Articles of the Gerontology Institute of the Academy of Medical Sciences of Ukraine, 2006, vol. 14, pp. 15-18. (In Russ.) 2. Гусев Е.И., Скворцова В.И. Ишемия головного мозга. М.: Медицина, 2001, 328 с., Gusev E.I., Skvortsova V.I. Cerebral ischemia. M.: Medicine, 2001, 328 p. (In Russ.) 3. Соловьева Э.Ю., Миронова О.П., Баранова О.А. и др. Свободнорадикальные процессы и антиоксидантная терапия при ишемии головного мозга. Журн. неврол. и психиат., 2008, т. 108, № 6, c. 88-94., Solovieva E.Yu., Mironova O.P., Baranova O.A. et al. Free-radical processes and antioxidant therapy for cerebral ischemia. Zhurn. nevrol. and psychiatrist., 2008, vol. 108, no. 6, pp. 88-94. (In Russ.) 4. Mitsui Y., Sahmelzer J.D., Zollman P.J. et al. Alpha-lipoic acid provides neuroprotection from ischemic-reperfusion injury of peripheral nerve. Journal of the Neurological Sciences, 1999, vol. 163, pp. 11-16., Mitsui Y., Sahmelzer J.D., Zollman P.J. et al. Alpha-lipoic acid provides neuroprotection from ischemic-reperfusion injury of peripheral nerve. Journal of the Neurological Sciences, 1999, vol. 163, pp. 11-16. 5. Clark W.M., Rinker L.G., Lessov N.S., Lowery S.L., Cipolla M.J. Efficacy of antioxidant therapies in transient focal ischemia in mice. Stroke, 2001, vol. 32, pp. 1000-1004., Clark W.M., Rinker L.G., Lessov N.S., Lowery S.L., Cipolla M.J. Efficacy of antioxidant therapies in transient focal ischemia in mice. Stroke, 2001, vol. 32, pp. 1000-1004.
|
|